Navigation Links
New Data Demonstrate Longer-Term Safety Profile of Esbriet®
Date:9/26/2011

about InterMune, please visit www.intermune.com.

Esbriet® is a registered trademark of InterMune, Inc.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of section 21E of the Securities Exchange Act of 1934, as amended, that reflect InterMune's judgment and involve risks and uncertainties as of the date of this release, including without limitation the statements related to the commercial launches of Esbriet® (pirfenidone) in the EU.  All forward-looking statements and other information included in this press release are based on information available to InterMune as of the date hereof, and InterMune assumes no obligation to update any such forward-looking statements or information.  InterMune's actual results could differ materially from those described in InterMune's forward-looking statements.  

Other factors that could cause or contribute to such differences include, but are not limited to, those discussed in detail under the heading "Risk Factors" in InterMune's most recent annual report on Form 10-K filed with the Securities and Exchange Commission (SEC) (the "Form 10-K"), and other periodic reports filed with the SEC, including but not limited to the following: (i) risks related to our ability to successfully launch and commercialize Esbriet in the EU, including successfully establishing a commercial operation in the EU and receiving favorable governmental pricing and reimbursement approvals in each EU country; (ii) risks related to the regulatory process for the company's product candidates, including the possibility that the results of the new 52-week Phase 3 clinical trial (ASCEND) having an FVC endpoint may not be satisfactory to the FDA for InterMune to receive regulatory approval for pirfenidone in the United States; (iii) risks related to the uncertain, lengthy and expensive clinical developm
'/>"/>

SOURCE InterMune, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. New Study Published in New England Journal of Medicine Shows Investigational BIBF 1120 Demonstrated Positive Trend in Reducing Lung Function Loss in Idiopathic Pulmonary Fibrosis
2. Inovio Pharmaceuticals Completes PENNVAX™-B HIV Vaccine Phase I Study, Demonstrates Best-in-Class T-Cell Immune Responses
3. Germgard Lighting Demonstrates the Worlds Most Effective Hand Sterilizer to Protect Against Contagion
4. NIH-Funded Study Demonstrates That Patients Receiving New CPR Devices (ResQPOD® and ResQPump™) and Cooling Have Improved Long-Term Brain Function Following Cardiac Arrest
5. New Digital Linear Accelerator Control System Demonstrates Treatment Time Savings of Up to 30 Percent
6. Obese Patients Treated With QNEXA Demonstrated Significant Improvement in Quality of Life
7. Inovio Pharmaceuticals Demonstrates Positive Immune Responses in Phase I Clinical Trial of SynCon™ H5N1 Influenza Vaccine and Launches Multi-Subtype Influenza Vaccine Phase I
8. New Research Demonstrates High Prevalence of Sexually Transmitted Disease Trichomonas Vaginalis and Potential of New Molecular Test to Improve Detection
9. Topaz Pharmaceuticals Ivermectin Cream In Vitro Data Demonstrates Activity Against Head Lice Eggs
10. Halozymes Ultrafast Insulin Demonstrates Reduced Variability of Insulin Absorption for Type 1 Diabetes Patients Using Insulin Pumps
11. CureFAKtor Pharmaceuticals Demonstrates that Novel Focal Adhesion Kinase (FAK) Inhibitors Decrease Pancreatic Cancer Tumor Blood Flow and Reduce Blood Vessel Density
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 2, 2015  Only a quarter of ... managing the patients they prescribe them to, according to ... School of Medicine (BUSM) and myCME , ... Daniel Alford, M.D. , director of BUSM,s ... program , said, "This indicates a critical need for ...
(Date:6/2/2015)... 2015  ErgoNurse, the leader in bedside safety management solutions, ... the United States , have formalized a ... and skilled nursing markets. ... Thousands of healthcare professionals ... advantage of the ErgoNurse products to stop unnecessarily utilizing their ...
(Date:6/2/2015)...  CytRx Corporation (NASDAQ: CYTR ), a biopharmaceutical ... that it has reached an agreement to settle the ... Court of Chancery, which names as defendants ... and officers, and names the Company as a nominal ... CytRx Corp. Stockholder Derivative Litigation , C.A. No. 9864-VCL, ...
Breaking Medicine Technology:Survey Results Show Few Doctors Are Very Confident Managing Patients on Opioids 2ErgoNurse and Briggs Healthcare Positioned to Completely Eliminate the Unnecessary Cost of Healthcare-Related Back Injuries 2CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 2CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 3CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 4
... FRANCISCO, Feb. 19 Inverseon, Inc. ( http://www.inverseon.com ) ... of the Proceedings of the National Academy of Sciences ... of an asthma phenotype in a murine model." The ... Duke Professor of Medicine at Duke University , ...
... France, February 18 , ... in Latin,America and Asia , ... :,SAN and NYSE : SNY), announced today that its ... study in Thailand to,assess the efficacy of the vaccine ...
Cached Medicine Technology:Inverseon's Founder and SAB Member Published in PNAS 2Sanofi Pasteur Dengue Vaccine Enters Pediatric Efficacy Clinical Study 2Sanofi Pasteur Dengue Vaccine Enters Pediatric Efficacy Clinical Study 3Sanofi Pasteur Dengue Vaccine Enters Pediatric Efficacy Clinical Study 4
(Date:6/2/2015)... (PRWEB) June 02, 2015 Erbelli’s Gourmet ... website to promote its handmade gourmet pizzas and calzones, ... though the website is new, the recipes are not—they ... 1995. The main feature of the site is the ... pictures and descriptions of all the items. You can ...
(Date:6/2/2015)... June 02, 2015 MAP Health Management, ... revenue cycle management for addiction treatment facilities, announced today ... President of Marketing. Mr. Smith will be responsible for ... awareness and visibility of MAP’s core message, products and ... the Marketing Manager at Cottonwood Financial in Irving, Texas, ...
(Date:6/2/2015)... June 02, 2015 ANT Wireless, ... highlights North Pole Engineering’s (NPE) announcement of three ... technologies: WASP-N, WASP-PoE-2 and WASP-PoE-3. WASP is a ... Bluetooth Smart® bridge solution that allows data collected ... WiFi or Ethernet networks. , The ...
(Date:6/2/2015)... The health care leaders who established ... value-based care will now offer health coverage for those ... The newly launched Crystal Run Health Plans has received ... Preferred Provider Organization (PPO) and Exclusive Provider Organization (EPO) ... and CEO, Hal Teitelbaum, MD, JD, MBA , ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 National Autism ... creative marketing, web design and development agency, to launch ... , National Autism Resources’ new website is ... of all ages diagnosed with autism. The site will ... offer an array of resources, from easy to understand ...
Breaking Medicine News(10 mins):Health News:Erbelli’s of Bradenton Launches New Mobile-Friendly Website 2Health News:Jared Smith Joins MAP Health Management, LLC, as Vice President of Marketing 2Health News:ANT Technology Incorporated in Second Generation WASP Bridge Products 2Health News:ANT Technology Incorporated in Second Generation WASP Bridge Products 3Health News:Leading Health Care Innovator Poised to Deliver New Health Coverage Options To The Hudson Valley Region 2Health News:Leading Health Care Innovator Poised to Deliver New Health Coverage Options To The Hudson Valley Region 3Health News:National Autism Resources Launches New Website, Delivering More Products and Services 2Health News:National Autism Resources Launches New Website, Delivering More Products and Services 3
... been mapped to the smallest fold for at least a century, ... each other. A study in Proceedings of the ... area of the rat brain and in so doing takes a ... brain connections was thought too complex to describe, but molecular biology ...
... Gardner HealthDay Reporter , MONDAY, Aug. 9 (HealthDay ... may spot Alzheimer,s disease long before symptoms start and might ... The findings, appearing in the August issue of the ... touting the use of such proteins, also known as biomarkers, ...
... Everyone experiences social stress, whether it is nervousness over ... angst over giving a speech. In a new report, ... to social stressors can influence the body,s immune system ... Lead author George Slavich, a postdoctoral fellow at ...
... Jenifer Goodwin HealthDay Reporter , MONDAY, Aug. 9 (HealthDay ... American girls, with many girls as young as 7 and 8 ... Rising rates of childhood obesity -- long linked to earlier sexual ... study, more than 1,200 girls ages 6 to 8 from Cincinnati, ...
... for oral cancer, which a dentist could perform by simply ... is set to be developed by researchers at the University ... The international research team, involving scientists in Sheffield, has ... Health to develop the test, which could provide an accurate ...
... cells," which help the brain map locations, have been found ... rat brain, according to new research from the Norwegian University ... our understanding of how the brain generates the internal maps ... to get to where we want to go. Five ...
Cached Medicine News:Health News:Brain's wiring: More network than pyramid? 2Health News:'Biomarkers' Could Spot Alzheimer's Disease Early, Studies Suggest 2Health News:'Biomarkers' Could Spot Alzheimer's Disease Early, Studies Suggest 3Health News:Stress gets under our skin 2Health News:Stress gets under our skin 3Health News:Many Girls Now Begin Puberty at Age 7, 8 2Health News:Many Girls Now Begin Puberty at Age 7, 8 3Health News:New 'dentist' test to detect oral cancer will save lives 2Health News:New 'dentist' test to detect oral cancer will save lives 3
For support, strength and control in your interventions, the RunWay Guide Catheter's large lumen and high-performance design represents a new era in guide catheters....
... developed over Guidants 20-year history, the VOYAGER ... for successful treatment outcomes. It combines a ... a lower profile shaft,more flexible markers, and ... cross tight and tortuous anatomy with even ...
... Utilizing technology developed over Guidants 20-year history, ... new foundation for successful treatment outcomes. It ... design with a lower profile shaft,more flexible ... you can cross tight and tortuous anatomy ...
Test for AFP...
Medicine Products: